SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-24-195009
Filing Date
2024-08-06
Accepted
2024-08-06 17:31:39
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 d878166ds3.htm S-3 379951
2 EX-1.2 d878166dex12.htm EX-1.2 177049
3 EX-4.2 d878166dex42.htm EX-4.2 285617
4 EX-5.1 d878166dex51.htm EX-5.1 26575
5 EX-23.2 d878166dex232.htm EX-23.2 1570
6 EX-FILING FEES d878166dexfilingfees.htm EX-FILING FEES 52893
7 GRAPHIC g878166dsp232a.jpg GRAPHIC 10905
8 GRAPHIC g878166dsp233.jpg GRAPHIC 5494
9 GRAPHIC g878166g54t10.jpg GRAPHIC 51837
  Complete submission text file 0001193125-24-195009.txt   1019136
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-281318 | Film No.: 241180658
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)